Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.
Latest News
Dermatology
Blueberry is committed to the development of innovative new therapies for the treatment of common dermatological disorders.
Nanomedicine
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
News
Fungal Infection – Not Just Toenails
Onychomycosis (fungal nail infection) and tinea pedis (athlete’s foot), are some of the most common forms of fungal infection in adults and are often the first [...]
Dave Edwards joins Blueberry Therapeutics
Blueberry Therapeutics are delighted to welcome Dave Edwards as Pharmaceutical Development Director, where he is responsible for CMC aspects of [...]
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.